|Day Low/High||145.01 / 147.46|
|52 Wk Low/High||121.50 / 219.94|
Here's how to book an investment in ABNB, according to the charts.
Here's my bottom line strategy.
If Wall Street snobs actually went to Walmart, they'd know you can't stop the American consumer who's got a clean balance sheet and is yearning to get outside.
If you had missed these last two days you may have missed 48 hours of the most important gains of the year.
I usually buy the dip on big 'down' days. On Wednesday I did buy the dip -- but only in gold.
Right now the newfound prevailing wisdom is clobbering the old kind and those who cling to the latter are destined to be run over.
Tech companies likely to see revenue growth inflect higher could continue doing well, as might relatively inexpensive ones that are poised to continue growing.
The rebellion against concept investing I think is not done but it will be if we get twice the GDP growth than we have had.
Here are five buys in technology companies that are just out of this world.
Stand aside for now.
The market's catalyst had everything to do with the virus... optimism that humankind might stuff that scourge back into Pandora's box.
When investing in a stock, it's not really that import why it's moving. Here's what is important to ask.
As power has changed hands in the White House, we can expect these names -- and themes -- to benefit.
I want to help you get rich, but to get rich carefully. Prudence dictates taking something off the table.
I am talking about themes that can stand the test not of today, or tomorrow, but for all of 2021 and beyond.
From Amazon to Zoom, here are my prognostications and best ideas for the new year.
The numbers tell the story and not the other way around. Don't forget that.
Until the $1200 payments in the spring, only a very small handful of people seemed interested in stocks. That changed it.
With these huge initial public offerings in Airbnb, DoorDash and Snowflake, we have to think about how much sense their valuations make; the logic behind them might surprise you.
Ocular Therapeutix and TG Therapeutics are still promising companies, but their recent runs higher make them pricey at this point.
They leave investors in a precarious position, as there is not a lot of a value left in what has become a very picked-over market.
Some markets are index-driven, but not this one, which makes finding good stock picks the approach to take in navigating it.
You can dismiss the market as irrational and crazy or you can work to navigate the action to make significant gains.
Keep in mind the positive catalysts as we wrap up the year.
Let me tell you what happened in 1999-2000 and what's happening now, and how it doesn't have to happen again.
Both IPOs and secondary offerings sopped up some excess liquidity and are contributing to a market pause as Friday trading begins.